[The predicive biomarkers of programmed death receptor-l/ligand antibodes in the treatement of non-small-cell lung cancer]

Zhonghua Jie He He Hu Xi Za Zhi. 2018 Oct 12;41(10):799-803. doi: 10.3760/cma.j.issn.1001-0939.2018.10.010.
[Article in Chinese]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • B7-H1 Antigen / antagonists & inhibitors*
  • Biomarkers, Tumor*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Humans
  • Lung Neoplasms / drug therapy*
  • Programmed Cell Death 1 Receptor*
  • Receptors, Death Domain

Substances

  • Antineoplastic Agents
  • B7-H1 Antigen
  • Biomarkers, Tumor
  • Programmed Cell Death 1 Receptor
  • Receptors, Death Domain